GAT229

GAT229

AOBS1951

CAS No: 1446648-15-2 

Chemical Name: 3-[(1R)-2-nitro-1-phenylethyl]-2-phenyl-1H-Indole, R-(+)-3-(2-Nitro-1-phenylethyl)-2-phenyl-1H-indole  

More details

940 Items

$38.35

$38.35 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
15 $25.07 Total: $125.37
110 $21.24 Total: $212.40
125 $18.00 Total: $449.88
150 $15.34 Total: $767.00
1100 $13.28 Total: $1,327.50

Overview

The S-(-)-enantiomer of GAT211, a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling that was found to amplify the therapeutic effect of endocannabinoids without the negative side effects of psychoactivity or tolerance. GAT229 was found to be a potent, Gαi/o-biased CB1 PAM without intrinsic activity, while the R-(+)-enantiomer, GAT228, was found to be an unbiased CB1 allosteric agonist. In radioligand binding assays, both GAT228 and GAT229 behaved as PAMs of orthosteric ligand binding, with GAT229 exhibiting higher potency and efficacy. Allosteric CB1R activation by GAT211 and its enantiomers could be a better therapeutic strategy for enhancing endogenous cannabinergic activity than targeting endocannabinoid-degrading enzymes with small-molecule inhibitors, with a lower likelihood of tolerance and dependence.

Chemical Properties

Molecular FormulaC22H18N2O2
Molecular Weight342.39
CAS Numbers889860-85-9
SolubilityDMSA: 20 mg/mL
Purity98% by HPLC

Storage and Handling

0°C (short term), -20°C (long term), desiccated

Customers who bought this product also bought: